查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771474

全球寡核苷酸合成市場：市場規模、佔有率、趨勢分析（按產品、應用、最終用途和地區）、細分市場預測（2025-2030 年）

Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 135 Pages | 商品交期: 2-10個工作天內

價格

寡核苷酸合成市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球寡核苷酸合成市場規模預計到2030年將達到88.3億美元，2025年至2030年期間的複合年成長率為13.2%。

正在進行臨床試驗的寡核苷酸療法的強大管道、基因編輯技術的進步以及生物技術公司不斷增加的研發支出是推動市場成長的一些主要因素。

寡核苷酸療法的參與者正處於後期臨床試驗階段，預計將在預測期內核准並商業化。各公司正加大對寡核苷酸療法的開發投入。 2023年10月，葛蘭素史克公司（GSK plc）和Arrowhead Pharmaceuticals宣布已與強生旗下的楊森製藥公司（Janssen Pharmaceuticals, Inc.，簡稱「楊森」）簽署協議，將JNJ-3989的全球獨家開發和商業化權利轉讓給葛蘭素史克。楊森最初於2018年從Arrowhead獲得JNJ-3989（之前稱為ARO-HBV）的許可。預計成熟製藥公司的類似努力將在預測期內推動市場成長。

美國醫療補助和醫療保險服務中心（負責實驗室）、聯邦貿易委員會（負責行銷）以及美國食品藥物管理局（負責套件和資訊）等政府機構參與監督基因組學和基因檢測的安全、適當和準確應用，並在基因組學的成功中發揮關鍵作用。美國國立衛生研究院（NIH）和惠康基金會（Wellcome Trust）等國際資助機構正在資助基因研究，預計將推動已開發經濟體和新興經濟體的基因組學研究。

2021 年 5 月，英國政府宣布撥款 4,340 萬美元（3,700 萬英鎊）用於基因組學研究和數據驅動舉措，這些資金將透過 2019 年 9 月啟動的英國功能基因組學計劃和英國基因組實施計劃提供。英國基因組策略將在英國基因組學計劃的幫助下實施，該計畫將獲得 1,990 萬美元（1,700 萬英鎊）用於研究新生兒定序的潛在價值。

寡核苷酸合成市場：概述分析

  • 服務部門將主導寡核苷酸合成市場，佔據 2024 年 31.5% 的最大收益佔有率。寡核苷酸部門預計將大幅成長，預測期內複合年成長率為 13.0%。
  • PCR 引子在 2024 年佔據寡核苷酸合成產業的最大收益佔有率。預計在預測期內，定序部分將以最快的複合年成長率成長。
  • 學術研究機構在 2024 年佔據寡核苷酸合成市場的主導地位，收益佔有率最大。預計在預測期內，製藥和生技公司部門將大幅成長。
  • 北美寡核苷酸合成市場在寡核苷酸合成產業佔據主導地位，2024 年的收益佔有率最大，為 31.9%。預計亞太寡核苷酸合成市場在預測期內的複合年成長率最快，為 14.9%。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 寡核苷酸合成市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL分析

第4章寡核苷酸合成市場：依產品分類的業務分析

  • 各產品市場佔有率（2024 年及 2030 年）
  • 細分儀表板：依產品
  • 市場規模預測及產品趨勢分析（2018-2030）
  • 寡核苷酸
  • 設備/合成器
  • 試劑
  • 服務

第5章寡核苷酸合成市場：按應用進行的業務分析

  • 按應用分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板：依用途
  • 按應用分類的市場規模預測和趨勢分析（2018-2030）
  • PCR引子
  • PCR檢測板
  • 定序
  • DNA微陣列
  • 螢光原位雜合反應（FISH）
  • 反義寡核苷酸
  • 其他用途

6.寡核苷酸合成市場：依最終用途的業務分析

  • 按最終用途分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板：依最終用途
  • 按最終用途分類的市場規模預測和趨勢分析（2018-2030 年）
  • 學術研究所
  • 診斷實驗室
  • 製藥和生物技術公司

第7章寡核苷酸合成市場：區域估計與趨勢分析

  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 按國家/地區（2018-2030 年）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區（2018-2030 年）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 按國家/地區（2018-2030 年）
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 按國家/地區（2018-2030 年）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區（2018-2030 年）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 參與企業概況
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher
    • Revvity Discovery Limited
    • Agilent Technologies, Inc.
    • Bio-Synthesis, Inc.
    • Kaneka Eurogentec SA
    • LGC Biosearch Technologies
    • Biolegio
    • Twist Bioscience
Product Code: GVR-2-68038-593-9

Oligonucleotide Synthesis Market Growth & Trends:

The global oligonucleotide synthesis market size is expected to reach USD 8.83 billion by 2030, registering a CAGR of 13.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The strong pipeline of oligonucleotide therapeutics in clinical trials, advancements in gene editing technologies, and increasing R&D spending by biotechnology companies are some of the major factors driving the market growth.

Oligonucleotide therapeutics participants are present in the late stages of clinical trials and are expected to be approved & commercialized over the forecast period. Companies have increased investments to develop oligonucleotide-based therapeutics. In October 2023, GSK plc and Arrowhead Pharmaceuticals announced a contract with Janssen Pharmaceuticals, Inc. (Janssen), a Johnson & Johnson company, to assign GSK exclusive worldwide rights to develop and commercialize JNJ-3989. Janssen initially in-licensed JNJ-3989 (previously ARO-HBV) from Arrowhead in 2018. Similar initiatives by well-established pharmaceutical companies are anticipated to drive market growth over the forecast period.

Government bodies, such as the Centers for Medicaid & Medicare Services for labs, the Federal Trade Commission for marketing, and the FDA for kits & information, have played a key role in the success of genomics, as they have been involved in monitoring the safe, appropriate, and accurate application of genomics & genetic tests. International funding bodies, such as NIH and Wellcome Trust, are engaged in providing funds for genetic studies, which is expected to fuel genomic studies in developed and emerging economies.

In May 2021, the UK government announced a funding of USD 43.4 million (GBP 37 million) for genomics research and data-driven initiatives, delivered via the UK Functional Genomics Initiative and Genome UK Implementation Plan, which was started in September 2019. The Genome UK strategy will be implemented with the help of the Genomics England project, which will receive USD 19.9 million (GBP 17 million) to investigate the potential value of newborn sequencing.

Oligonucleotide Synthesis Market Report Highlights:

  • The services segment dominated the oligonucleotide synthesis market, accounting for the largest revenue share of 31.5% in 2024. The oligonucleotides segment is expected to grow at a significant CAGR of 13.0% over the forecast period.
  • PCR primers led the oligonucleotide synthesis industry with the largest revenue share in 2024. The sequencing segment is expected to grow at the fastest CAGR over the forecast period.
  • The academic research institutes dominated the oligonucleotide synthesis market with the largest revenue share in 2024. The pharmaceutical and biotechnology companies segment is expected to grow significantly over the forecast period.
  • The North America oligonucleotide synthesis market dominated the oligonucleotide synthesis industry with the largest revenue share of 31.9% in 2024. The Asia Pacific oligonucleotide synthesis market is expected to grow at the fastest CAGR of 14.9% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Oligonucleotide Synthesis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Oligonucleotide Synthesis Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Oligonucleotides
    • 4.4.1. Oligonucleotides Market, 2018 - 2030 (USD Million)
    • 4.4.2. Product Type
      • 4.4.2.1. Product Type Market, 2018 - 2030 (USD Million)
      • 4.4.2.2. Column-based Oligos
        • 4.4.2.2.1. Column-based Oligos Market, 2018 - 2030 (USD Million)
      • 4.4.2.3. Array-based Oligos
        • 4.4.2.3.1. Array-based Oligos Market, 2018 - 2030 (USD Million)
    • 4.4.3. Nucleic Acid Type
      • 4.4.3.1. Nucleic Acid Type Market, 2018 - 2030 (USD Million)
      • 4.4.3.2. DNA
        • 4.4.3.2.1. DNA Market, 2018 - 2030 (USD Million)
      • 4.4.3.3. RNA
        • 4.4.3.3.1. RNA Market, 2018 - 2030 (USD Million)
  • 4.5. Equipment/Synthesizer
    • 4.5.1. Equipment/Synthesizer Market, 2018 - 2030 (USD Million)
  • 4.6. Reagents
    • 4.6.1. Reagents Market, 2018 - 2030 (USD Million)
  • 4.7. Services
    • 4.7.1. Services Market, 2018 - 2030 (USD Million)
    • 4.7.2. Oligo Synthesis
      • 4.7.2.1. Oligo Synthesis Market, 2018 - 2030 (USD Million)
      • 4.7.2.2. 25 nmol
        • 4.7.2.2.1. 25 nmol Market, 2018 - 2030 (USD Million)
      • 4.7.2.3. 50 nmol
        • 4.7.2.3.1. 50 nmol Market, 2018 - 2030 (USD Million)
      • 4.7.2.4. 200 nmol
        • 4.7.2.4.1. 200 nmol Market, 2018 - 2030 (USD Million)
      • 4.7.2.5. 1000nmol
        • 4.7.2.5.1. 1000nmol Market, 2018 - 2030 (USD Million)
      • 4.7.2.6. 10,000 nmol
        • 4.7.2.6.1. 10,000 nmol Market, 2018 - 2030 (USD Million)
    • 4.7.3. Purification
      • 4.7.3.1. Purification Market, 2018 - 2030 (USD Million)
    • 4.7.4. Modification
      • 4.7.4.1. Modification Market, 2018 - 2030 (USD Million)

Chapter 5. Oligonucleotide Synthesis Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. PCR Primers
    • 5.4.1. Oligonucleotide Synthesis Market, in PCR Primers, 2018 - 2030 (USD Million)
  • 5.5. PCR Assays and Panels
    • 5.5.1. Oligonucleotide Synthesis Market, in PCR Assays and Panels, 2018 - 2030 (USD Million)
  • 5.6. Sequencing
    • 5.6.1. Oligonucleotide Synthesis Market, in Sequencing, 2018 - 2030 (USD Million)
  • 5.7. DNA Microarrays
    • 5.7.1. Oligonucleotide Synthesis Market, in DNA Microarrays, 2018 - 2030 (USD Million)
  • 5.8. Fluorescence In Situ Hybridization (FISH)
    • 5.8.1. Oligonucleotide Synthesis Market, in Fluorescence In Situ Hybridization (FISH), 2018 - 2030 (USD Million)
  • 5.9. Antisense Oligonucleotides
    • 5.9.1. Oligonucleotide Synthesis Market, in Antisense Oligonucleotides, 2018 - 2030 (USD Million)
  • 5.10. Other Applications
    • 5.10.1. Oligonucleotide Synthesis Market, in Other Applications, 2018 - 2030 (USD Million)

Chapter 6. Oligonucleotide Synthesis Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Academic Research Institutes
    • 6.4.1. Oligonucleotide Synthesis Market, in Academic Research Institutes, 2018 - 2030 (USD Million)
  • 6.5. Diagnostic Laboratories
    • 6.5.1. Oligonucleotide Synthesis Market, in Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • 6.6. Pharmaceutical and Biotechnology Companies
    • 6.6.1. Oligonucleotide Synthesis Market, in Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)

Chapter 7. Oligonucleotide Synthesis Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. Germany Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. UK
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. UK Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. China Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. India Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Japan
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. Japan Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. South Korea Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Thermo Fisher Scientific Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Type Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Merck KGaA
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Type Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Danaher
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Type Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Revvity Discovery Limited
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Type Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Agilent Technologies, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Type Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Bio-Synthesis, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Type Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Kaneka Eurogentec S.A.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Type Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. LGC Biosearch Technologies
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Type Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Biolegio
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Type Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Twist Bioscience
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Type Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global oligonucleotide synthesis market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 5. Global oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 6. Global oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 7. North America oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 9. North America oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 10. North America oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 11. U.S. oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 12. U.S. oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 13. U.S. oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 14. Canada oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 15. Canada oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Canada oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 17. Mexico oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 18. Mexico oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 19. Mexico oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 20. Europe oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 21. Europe oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 22. Europe oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 23. Europe oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Germany oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 25. Germany oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 26. Germany oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 27. UK oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 28. UK oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 29. UK oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 30. France oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 31. France oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 32. France oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Italy oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 34. Italy oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 35. Italy oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 36. Spain oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 37. Spain oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 38. Spain oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 39. Denmark oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 40. Denmark oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 41. Denmark oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 42. Sweden oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 43. Sweden oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 44. Sweden oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 45. Norway oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 46. Norway oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 47. Norway oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 52. China oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 53. China oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 54. China oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 55. India oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 56. India oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 57. India oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 58. Japan oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 59. Japan oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 60. Japan oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Australia oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 62. Australia oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 63. Australia oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 64. South Korea oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 65. South Korea oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 66. South Korea oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 67. Thailand oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 68. Thailand oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 69. Thailand oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Latin America oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 71. Latin America oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 72. Latin America oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 73. Latin America oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 74. Brazil oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 75. Brazil oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 76. Brazil oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 77. Argentina oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 78. Argentina oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 79. Argentina oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 84. South Africa oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 85. South Africa oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 86. South Africa oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 90. UAE oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 91. UAE oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 92. UAE oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
  • Table 93. Kuwait oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
  • Table 94. Kuwait oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 95. Kuwait oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Oligonucleotide synthesis market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Product outlook (USD Million)
  • Fig. 9 Application outlook (USD Million)
  • Fig. 10 End use Market snapshot
  • Fig. 11 Competitive landscape
  • Fig. 12 Oligonucleotide synthesis market dynamics
  • Fig. 13 Oligonucleotide synthesis market: Porter's five forces analysis
  • Fig. 14 Oligonucleotide synthesis market: Pestle analysis
  • Fig. 15 Oligonucleotide synthesis market: Product segment dashboard
  • Fig. 16 Oligonucleotide synthesis market: Product market share analysis, 2024 & 2030
  • Fig. 17 Oligonucleotides market, 2018 - 2030 (USD Million)
  • Fig. 18 Product type market, 2018 - 2030 (USD Million)
  • Fig. 19 Column-based Oligos market, 2018 - 2030 (USD Million)
  • Fig. 20 Array-based Oligos market, 2018 - 2030 (USD Million)
  • Fig. 21 Nucleic acid type market, 2018 - 2030 (USD Million)
  • Fig. 22 DNA market, 2018 - 2030 (USD Million)
  • Fig. 23 RNA market, 2018 - 2030 (USD Million)
  • Fig. 24 Equipment/Synthesizer market, 2018 - 2030 (USD Million)
  • Fig. 25 Reagents market, 2018 - 2030 (USD Million)
  • Fig. 26 Services market, 2018 - 2030 (USD Million)
  • Fig. 27 Oligo Synthesis market, 2018 - 2030 (USD Million)
  • Fig. 28 25 nmol market, 2018 - 2030 (USD Million)
  • Fig. 29 50 nmol market, 2018 - 2030 (USD Million)
  • Fig. 30 200 nmol market, 2018 - 2030 (USD Million)
  • Fig. 31 1000 nmol market, 2018 - 2030 (USD Million)
  • Fig. 32 10,000 nmol market, 2018 - 2030 (USD Million)
  • Fig. 33 Purification market, 2018 - 2030 (USD Million)
  • Fig. 34 Modification market, 2018 - 2030 (USD Million)
  • Fig. 35 Oligonucleotide synthesis market: Application segment dashboard
  • Fig. 36 Oligonucleotide synthesis market: Application market share analysis, 2024 & 2030
  • Fig. 37 Oligonucleotide synthesis market, in PCR Primers, 2018 - 2030 (USD Million)
  • Fig. 38 Oligonucleotide synthesis market, in PCR Assays and Panels, 2018 - 2030 (USD Million)
  • Fig. 39 Oligonucleotide synthesis market, in Sequencing, 2018 - 2030 (USD Million)
  • Fig. 40 Oligonucleotide synthesis market, in DNA Microarrays, 2018 - 2030 (USD Million)
  • Fig. 41 Oligonucleotide synthesis market, in Fluorescence In Situ Hybridization (FISH), 2018 - 2030 (USD Million)
  • Fig. 42 Oligonucleotide synthesis market, in Antisense Oligonucleotide, 2018 - 2030 (USD Million)
  • Fig. 43 Oligonucleotide synthesis market, in Other Applications, 2018 - 2030 (USD Million)
  • Fig. 44 Oligonucleotide synthesis market: End use segment dashboard
  • Fig. 45 Oligonucleotide synthesis market: End use market share analysis, 2024 & 2030
  • Fig. 46 Oligonucleotide synthesis market, in Academic Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 47 Oligonucleotide synthesis market, in Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • Fig. 48 Oligonucleotide synthesis market, in Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 49 Oligonucleotide synthesis market revenue, by region
  • Fig. 50 Regional marketplace: Key takeaways
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 53 U.S. country dynamics
  • Fig. 54 U.S. oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 55 Canada country dynamics
  • Fig. 56 Canada oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico country dynamics
  • Fig. 58 Mexico oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 59 Europe oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 60 Germany country dynamics
  • Fig. 61 Germany oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 62 UK country dynamics
  • Fig. 63 UK oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 64 France country dynamics
  • Fig. 65 France oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 66 Italy country dynamics
  • Fig. 67 Italy oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 68 Spain country dynamics
  • Fig. 69 Spain oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 70 Denmark country dynamics
  • Fig. 71 Denmark oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 72 Sweden country dynamics
  • Fig. 73 Sweden oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 74 Norway country dynamics
  • Fig. 75 Norway oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 76 Asia Pacific oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 77 China country dynamics
  • Fig. 78 China oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 79 India country dynamics
  • Fig. 80 India oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 81 Japan country dynamics
  • Fig. 82 Japan oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 83 Australia country dynamics
  • Fig. 84 Australia oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 85 South Korea country dynamics
  • Fig. 86 South Korea oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 87 Thailand country dynamics
  • Fig. 88 Thailand oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 89 Latin America oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 90 Brazil country dynamics
  • Fig. 91 Brazil oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 92 Argentina country dynamics
  • Fig. 93 Argentina oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 94 Middle East & Africa oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 95 South Africa country dynamics
  • Fig. 96 South Africa oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 97 Saudi Arabia country dynamics
  • Fig. 98 Saudi Arabia oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 99 UAE country dynamics
  • Fig. 100 UAE oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 101 Kuwait country dynamics
  • Fig. 102 Kuwait oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 103 Company categorization
  • Fig. 104 Company market position analysis
  • Fig. 105 Strategic framework